A Tasmanian researcher will use a $50,000 national prize for stem cell research which may help treat conditions like Alzheimer's disease and multiple sclerosis.

Dr Kaylene Young has won an inaugural Metcalf Prize from the National Stem Cell Foundation of Australia.

Her research has already uncovered that people have lazy or inactive brain cells and are common in people with multiple sclerosis, Alzheimer's and other degenerative diseases.

They are also found in people with a brain injury.

She has told ABC Local Radio her research will help improve the understanding of brain cell behaviour in order to treat disorders or damage.

She believes she can persuade cells to self repair and wake up, either by stimulation or electrically.

"[I'm] really trying to find what it is that controls their behaviours, what makes them divide, what makes them able to generate different types of brain cells in order to be able to use them for therapeutic treatments for things like Alzheimer's disease, multiple sclerosis and even brain cancers," Dr Young said.

"What I am really trying to do is push our endogenous stem cells, the stem cells that are already in our brain every day, to just work that little bit harder."

Dr Young says the award is a great honour.

"In this way we are sort of able to build up stem cell research in Tasmania and the award itself highlights the fact that we are doing really great work in the state in this area."

Melbourne researcher Jose Polo has also received an inaugural Metcalf Prize to further his stem cell work which could eventually help treat degenerative diseases.

Free trade is the oldest argument in federal politics and the issue that literally defined the federation era but opposition exists to the TPP, courtesy of the Investor-State Dispute Resolutions clause.